DCDC Kidney Care launches Academy of Healthcare to build India’s dialysis workforce
New Yamuna Vihar facility to train 40 students annually through diploma-led, hands-on renal care education
New Yamuna Vihar facility to train 40 students annually through diploma-led, hands-on renal care education
The perinatology CME at Navi Mumbai brought together more than 100 obstetricians, pediatricians, and neonatologists
The license is valid for five years, effective from April 9, 2026
Landmark procedure restores 32-year-old CKD patient’s health, highlighting how public insurance is widening access to advanced renal care
In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga
A key milestone in this journey has been the introduction of TREAT Program, a first-of-its-kind clinical initiative introduced in India
Call it a major breakthrough for diagnostic imaging
Desidustat tablets are a novel oral HIF-PHI approved for treating anaemia in non-dialysis adult CKD patients
The new facilities are designed to provide focused, patient-centric care through advanced diagnostics, minimally invasive treatments, and multidisciplinary expertise
Subscribe To Our Newsletter & Stay Updated